EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:135193 - fospropofol
| Formula | C13H21O5P |
| Net Charge | 0 |
| Average Mass | 288.280 |
| Monoisotopic Mass | 288.11266 |
| SMILES | CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O |
| InChI | InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16) |
| InChIKey | QVNNONOFASOXQV-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | anti-obesity agent Any substance which is used to reduce or control weight. antiviral agent A substance that destroys or inhibits replication of viruses. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. vulnerary A drug used in treating and healing of wounds. anti-inflammatory agent Any compound that has anti-inflammatory effects. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. hepatoprotective agent Any compound that is able to prevent damage to the liver. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| fospropofol (CHEBI:135193) has role analgesic (CHEBI:35480) |
| fospropofol (CHEBI:135193) has role anti-arrhythmia drug (CHEBI:38070) |
| fospropofol (CHEBI:135193) has role anti-inflammatory agent (CHEBI:67079) |
| fospropofol (CHEBI:135193) has role anti-obesity agent (CHEBI:74518) |
| fospropofol (CHEBI:135193) has role antidepressant (CHEBI:35469) |
| fospropofol (CHEBI:135193) has role antihypertensive agent (CHEBI:35674) |
| fospropofol (CHEBI:135193) has role antineoplastic agent (CHEBI:35610) |
| fospropofol (CHEBI:135193) has role antiviral agent (CHEBI:22587) |
| fospropofol (CHEBI:135193) has role cardiovascular drug (CHEBI:35554) |
| fospropofol (CHEBI:135193) has role hepatoprotective agent (CHEBI:62868) |
| fospropofol (CHEBI:135193) has role neuroprotective agent (CHEBI:63726) |
| fospropofol (CHEBI:135193) has role vulnerary (CHEBI:73336) |
| fospropofol (CHEBI:135193) is a alkylbenzene (CHEBI:38976) |
| INN | Source |
|---|---|
| fospropofol | WHO MedNet |
| Synonyms | Source |
|---|---|
| fospropofol disodium | DrugCentral |
| fospropofol sodium | DrugCentral |
| lusedra | DrugCentral |
| Manual Xrefs | Databases |
|---|---|
| 3249 | DrugCentral |
| HMDB0015661 | HMDB |
| Registry Numbers | Sources |
|---|---|
| CAS:258516-89-1 | DrugCentral |
| Citations |
|---|